Cargando…
Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma
Autores principales: | Tanba, Kazuna, Chinen, Yoshiaki, Uchiyama, Hitoji, Uoshima, Nobuhiko, Shimura, Kazuho, Fuchida, Shinichi, Kiyota, Miki, Nakao, Mitsushige, Shimura, Yuji, Kobayashi, Tsutomu, Horiike, Shigeo, Wada, Katsuya, Shimazaki, Chihiro, Kaneko, Hiroto, Kobayashi, Yutaka, Taniwaki, Masafumi, Kuroda, Junya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802597/ https://www.ncbi.nlm.nih.gov/pubmed/29367648 http://dx.doi.org/10.1038/s41408-017-0043-6 |
Ejemplares similares
-
Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib‐based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patients
por: Kawaji‐Kanayama, Yuka, et al.
Publicado: (2021) -
Chromosomal abnormality variation detected by G‐banding is associated with prognosis of diffuse large B‐cell lymphoma treated by R‐CHOP‐based therapy
por: Mizuno, Yoshimi, et al.
Publicado: (2018) -
Serum Albumin Levels Strongly Predict Survival Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Combined Chemotherapy
por: Kaneko, Hiroto, et al.
Publicado: (2022) -
High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif
por: Tsukamoto, Taku, et al.
Publicado: (2017) -
Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma
por: Matsumura‐Kimoto, Yayoi, et al.
Publicado: (2020)